The Manila Times·3 min read·hard
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
✦AI Summary
CancerVax, Inc. has developed a 'Smart mRNA' platform designed to disguise cancer cells as common viral infections, triggering the body's pre-existing T-cell immunity to attack the tumor. The company has successfully completed the design and in-vitro validation of this polyepitope construct.
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to activate pre-existing T-cell immunity
healthtechnologybusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in